Practical issues in the management of novel oral anticoagulants—cardioversion and ablation
Is pulmonary vein isolation still the cornerstone in atrial fibrillation ablation?
The role of transcription factors in atrial fibrillation
Hybrid approaches in atrial fibrillation ablation: why, where and who?
Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
Can oral anticoagulants be stopped safely after a successful atrial fibrillation ablation?
Adjunct ablation strategies for persistent atrial fibrillation—beyond pulmonary vein isolation
Alternative medicine in atrial fibrillation treatment—Yoga, acupuncture, biofeedback and more
Dysfunction of the autonomic nervous system in atrial fibrillation
Left atrial appendage closure for thromboembolism prevention in patients with atrial fibrillation: advances and perspectives
The focused issue “Atrial Fibrillation” was commissioned by the editorial office, Journal of Thoracic Disease without any sponsorship or funding. Yunlong Xia and Dhanunjaya Lakkireddy served as the unpaid Guest Editors for the focused issue.